Tags |
|
|
Links |
|
|
Advice You - Say No to Business Bankruptcy
When your business runs into troubled waters where you have borrowed money, incurred huge debts and are now unable to repay these obligations, the instant solution that comes to mind is that of filing for Business Bankruptc
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
y. The lure of starting afresh, after seeking solace in Chapter 11 is always more appealing than trying to find means to clear the debt trap that you have fallen into.
However, no matter how grave the consequences, it is o
However, no matter how grave the consequences, it is o
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ten better to say no to Business bankruptcy. Bankruptcy should be considered only as a last resort and out-of-court restructuring alternatives should be given a thought.
The primary reason, people avoid filing for bankrupt
The primary reason, people avoid filing for bankrupt
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
y is that it will lead to them losing direct control over their business. Once you start functioning under the umbrella of Chapter 11, there will inevitably be other creditors and new masters ready to take on your share of
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ontrol as well as decision making powers. The company will be put under tremendous constraints which many third parties like vendors, landlords, service providers etc who have a vested interest may start acting on, as well.
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
Moreover, the debtor will have to start explaining how and why so many things are being done while at the same time have to seek the court’s approval to succeed.
Another important feature of filing for business bankruptcy
Another important feature of filing for business bankruptcy
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
and the reason one must try to avoid it is the expenditure it incurs. Not only does it take too long to get all the procedural matters sorted out, but it turns out to be a costly affair. A bankrupt company will need to find
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
expert legal counsel, the rates of which may truly be unaffordable. Additionally there will be business advisors, filing fees, administrative expenses, all of which can run up a huge tab.
The resolving of bankruptcies can
The resolving of bankruptcies can
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ake far too long which tends to be another reason to avoid them. Moreover the process is slow, tedious and cumbersome. The management will be obligated to spend a significant amount of time planning for and attending court
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
hearings to get the approval of actions that they want to take — and therefore ending up spending little time actually running the business. This may lead to lost opportunities in business, another chink in the armor of ban
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ruptcy.
The long drawn out process of bankruptcy laws combined with the uncertainty it accords, also leads to employee dissatisfaction and low employee morale. This may lead to high attrition rates, which in turn lead to h
The long drawn out process of bankruptcy laws combined with the uncertainty it accords, also leads to employee dissatisfaction and low employee morale. This may lead to high attrition rates, which in turn lead to h
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
gh attendant costs. Hiring and training new employees increases the burden of costs and reduces motivation levels considerably.
Given all the above factors, bankruptcy is a risky decision. Obviously, the reorganization of
Given all the above factors, bankruptcy is a risky decision. Obviously, the reorganization of
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
company under Chapter 11 is designed to create a fresh start and preserve or enhance business opportunities, but often the process can be quite damaging, perhaps as much as the initial problem and reason of bankruptcy.
Ce
Ce
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
rtain industries and businesses are totally averse to filing for bankruptcy. Companies, typically, in the large-scale, long-term construction industry are not good candidates for Chapter 11. One reason for this is the risk
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
f continued payment or progress billing for the work being done. Another reason is that subcontractors may have the right to lien property if they are not fully compensated. Thus, the potential benefits that may accrue as a
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
result of the debtor company being able to avoid immediate payment for certain pre-petition obligations are greatly limited. Lastly, it is difficult for a debtor in the large-scale company contracting business to bid for an
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
win new businesses when under the Chapter 11 clause. Most potential bidders are likely to turn their backs on such cases.
An out-of-court restructuring alternative should be considered as opposed to business bankruptcy as
An out-of-court restructuring alternative should be considered as opposed to business bankruptcy as
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
it is not only attainable, but because it can be done relatively faster, with less extraneous activity as well as less expense. Also, because a company is dealing directly with its most important creditors it tends to be a
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
better option. While the pool of interested parties becomes smaller, it also means that the financial losses are not shared as equally as it usually is in a Chapter 11. In these situations, solid planning and communication
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ith the major stakeholders is critical. All in all, business bankruptcy may not be the best solution to a company under-performing. It should be taken only as a last resort solution only when all other options are exhausted
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/90671/adviceyou-Say-No-to-Business-Bankruptcy.html">Say No to Business Bankruptcy</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/90671/adviceyou-Say-No-to-Business-Bankruptcy.html]Say No to Business Bankruptcy[/url]
Related Articles:
Internet Marketing Business - 3 Steps To Creating An Internet Marketing Business
Bookmark it:
|